You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

gastro-esophageal junction neoplasms

Showing 1 - 25 of 4,159
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Stomach Tumors Trial in Wuhan (Fruquintinib, Sintilimab)

Not yet recruiting
  • Stomach Neoplasms
  • Wuhan, Hubei, China
    Wuhan Union Hospital, China
Nov 22, 2022

Gastric or Gastro-esophageal Junction (GEJ) or Esophageal Adenocarcinoma (EAC) Trial in Poland, Spain, United States (NT-I7,

Active, not recruiting
  • Gastric or Gastro-esophageal Junction (GEJ) or Esophageal Adenocarcinoma (EAC)
  • Louisville, Kentucky
  • +5 more
Dec 7, 2022

Advanced Gastric and Gastro-esophageal Junction Adenocarcinoma Trial in Beijing (sintilimab, nab-paclitaxel)

Recruiting
  • Advanced Gastric and Gastro-esophageal Junction Adenocarcinoma
  • Beijing, China
    Chinese Academy of Medical Sciences
Mar 9, 2022

MSI-H/dMMR Gastroesophageal-junction Cancer, MSI-H/dMMR Gastric Cancer Trial (S095029, Pembrolizumab 200 mg)

Not yet recruiting
  • MSI-H/dMMR Gastroesophageal-junction Cancer
  • MSI-H/dMMR Gastric Cancer
  • (no location specified)
Oct 30, 2023

Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Gastric Cardia Trial in

Active, not recruiting
  • Adenocarcinoma of the Esophagus
  • +5 more
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jul 25, 2022

Gastro-Esophageal Junction Adenocarcinoma, Gastric Cancer Trial in United States (Nab-paclitaxel 150 mg/m^2, Oxaliplatin 85

Active, not recruiting
  • Gastro-Esophageal Junction Adenocarcinoma
  • Gastric Cancer
  • Nab-paclitaxel 150 mg/m^2
  • +3 more
  • Chicago, Illinois
  • +7 more
Feb 16, 2022

Gastric Cancer Stage IV Trial in Seoul (olaparib+pembrolizumab+paclitaxel)

Not yet recruiting
  • Gastric Cancer Stage IV
  • Seoul, Korea, Republic of
    Severance Hospital
Aug 29, 2021

Squamous Cell Carcinoma, Adenocarcinoma, Esophageal Cancer Trial in Amsterdam (Carboplatin, Paclitaxel, panitumumab)

Completed
  • Squamous Cell Carcinoma
  • +3 more
  • Amsterdam, Netherlands
    Academic Medical Center
Apr 19, 2021

Gastric Cancer, Gastro-esophageal Junction Cancer, Pancreatic Ductal Adenocarcinoma Trial in Worldwide (AZD5863)

Recruiting
  • Gastric Cancer
  • +3 more
  • Jacksonville, Florida
  • +16 more
Aug 17, 2023

Clinical & Pathological Studies of Upper Gastrointestinal

Recruiting
  • Stomach Cancer
  • +4 more
  • Blood draw
  • Tissue tumor biopsy
  • Stanford, California
    Stanford University School of Medicine
Jul 29, 2021

Gastric Cancer, Gastro-oesophageal Junction Cancer, Immunotherapy Trial in Shanghai (Anlotinib Plus Toripalimab)

Recruiting
  • Gastric Cancer
  • +4 more
  • Anlotinib Plus Toripalimab
  • Shanghai, China
    Department of Medical Oncology, Shanghai Changzheng Hospital
Dec 28, 2020

Gastric Cancer, Gastro Esophageal Junctional Cancer, Cancer Trial (68Ga-FAPi-46)

Not yet recruiting
  • Gastric Cancer
  • +2 more
  • (no location specified)
Jun 12, 2023

Gastric Adenocarcinoma, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Chuo Ku (TRK-950, Ramucirumab,

Not yet recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • TRK-950
  • +2 more
  • Chuo Ku, Japan
    Osaka International Cancer Institute
Sep 14, 2023

Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage

Active, not recruiting
  • Clinical Stage III Gastric Cancer AJCC v8
  • +7 more
  • Duarte, California
  • +30 more
Jan 7, 2023

Oesophageal Carcinoma Trial in Australia (APR-246)

Terminated
  • Oesophageal Carcinoma
  • Clayton, Victoria, Australia
  • +4 more
Dec 10, 2021

Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma Trial in Guangzhou (zolbetuximab)

Completed
  • Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma
  • Guangzhou, China
    Site CN86001
Jan 11, 2022

Gastric Cancer, Esophageal Cancer Trial (FerroTrace® and FerroMag Sentinel Lymph Node Mapping (SLNM) System)

Not yet recruiting
  • Gastric Cancer
  • Esophageal Cancer
  • FerroTrace® and FerroMag Sentinel Lymph Node Mapping (SLNM) System
  • (no location specified)
Jun 2, 2023

Minimally Invasive Surgery of the Gastro-esophageal Junction

Recruiting
  • Achalasia
  • +4 more
    • Ottawa, Ontario, Canada
      Ottawa Hospital Research Institute
    Mar 21, 2022

    Stomach Cancer, Gastro Esophageal Junction Cancer Trial in Amsterdam, Eindhoven (Atezolizumab, Capecitabine, Oxaliplatin)

    Recruiting
    • Stomach Cancer
    • Gastro Esophageal Junction Cancer
    • Amsterdam, Netherlands
    • +1 more
    Apr 19, 2021

    Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Beijing (CS1001 mAb, CS1001 , Oxaliplatin)

    Active, not recruiting
    • Gastric Adenocarcinoma
    • Gastroesophageal Junction Adenocarcinoma
    • CS1001 monoclonal antibody
    • +3 more
    • Beijing, China
      Beijing Cancer Hospital
    Sep 27, 2022

    Metastatic Gastric Cancer, Adenocarcinoma of the Gastro-oesophageal Junction Trial in Amsterdam (Docetaxel, Oxaliplatin,

    Active, not recruiting
    • Metastatic Gastric Cancer
    • Adenocarcinoma of the Gastro-oesophageal Junction
    • Docetaxel, Oxaliplatin, Capecitabin, Bevacizumab
    • Docetaxel, Oxaliplatin, Capecitabin, Bevacizumab, Trastuzumab
    • Amsterdam, Netherlands
      Netherlands Cancer Institute
    Jan 26, 2021

    Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Diffuse Adenocarcinoma of the Stomach Trial in

    Terminated
    Has Results
    • Adenocarcinoma of the Esophagus
    • +13 more
    • oblimersen sodium
    • +2 more
    • Bronx, New York
      Montefiore Medical Center
    Jan 29, 2021

    Nivolumab in Treatment of Early Stage Esophageal or

    Not yet recruiting
    • Esophageal Carcinoma
    • Gastroesophageal Junction Carcinoma
      • Louisville, Kentucky
      • +2 more
      Mar 21, 2023

      Clinical Stage I Esophageal Adenocarcinoma AJCC v8, Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical

      Not yet recruiting
      • Clinical Stage I Esophageal Adenocarcinoma AJCC v8
      • +5 more
      • Biospecimen Collection
      • +9 more
      • Scottsdale, Arizona
      • +2 more
      Oct 11, 2023

      Resectable Gastric or Gastroesophageal Junction Adenocarcinoma Trial (Cadonilimab, AK117, Oxaliplatin)

      Not yet recruiting
      • Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
      • (no location specified)
      Jul 17, 2023